Pharma Mirror
SEPTEMBER 11, 2022
Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
pharmaphorum
JULY 7, 2022
Read on to find out about reaching the gold standard of lung cancer screening, the promise of therapeutic cancer vaccines, why diversity is essential in oncology trials, and much more. Realising the promise of cancer vaccines. Immunotherapy: building the fourth pillar of cancer treatment. Read Deep Dive: Oncology in full.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 2, 2022
Influencer culture has well and truly taken over the internet, with numerous benefits on offer for pharmaceutical companies in the healthcare influencer space. Company profile: Vinehealth. Viseven’s CEO, Nataliya Andreychuk, details how pharma companies can use modular content to maximise omnichannel marketing.
pharmaphorum
APRIL 30, 2021
Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks.
pharmaphorum
FEBRUARY 26, 2021
The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Maria Chatzou Dunford. The landscape for UK SMEs post-COVID.
pharmaphorum
AUGUST 13, 2020
New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. Think you need to build manufacturing of a vaccine before you know what’s working.
PharmaShots
MARCH 9, 2023
Award & Nominations: For her contributions to the pharmaceutical sector and business, Emma received the rank of Dame Commander (DBE) in the 2020 Queen's Birthday Honours. With more than $50 billion in annual global revenue, Janssen has grown to be the second-largest innovative pharmaceutical company under her direction.
Expert insights. Personalized for you.
52 
Let's personalize your content